‘Dietary Supplement Class Actions: Recent Overlap With Traditional FDA Enforcement,’ by Rend Al-Mondhiry and Jennifer Adams, Regulatory Affairs Professional Society, RAPS, June 2020.
‘FDA’s Ongoing Review of CBD and its Impact on Class Action Litigation’ by Rend-Al-Mondhiry and Megan Olsen, Vice President and Associate General Counsel, Counsel for Responsible Nutrition. Washington Legal Foundation, May 7, 2020.
‘Update on the Regulatory Status of Cannabidiol in Food and Dietary Supplements,’ by Rend Al-Mondhiry, Regulatory Affairs Professional Society (RAPS), June 12, 2019.
‘State Regulation of CBD,’ by Rend Al-Mondhiry, April 16, 2019, Natural Products Insider.
‘Ninth Circuit Provides Rare Clarity on Preemption in Dietary Supplement Structure/Function Claim Challenges,’ by Rend Al-Mondhiry and Megan Olsen, Assistant General Counsel, Council for Responsible Nutrition, Washington Legal Foundation, February 28, 2019.
‘Don’t Let State Legislation Affecting Food, Dietary Supplements Fly Under Radar,’ by Rend Al-Mondhiry,
‘Update on the Amarin-ITC Case and the Issues at Stake,’ by Rend Al-Mondhiry and Jennifer Adams, Regulatory Focus, Regulatory Affairs Professionals Society, July 2018.
‘8 Things I Learned from 8 Years as a Dietary Supplement Trade Association Attorney,’ by Rend Al-Mondhiry, New Hope Network, March 1, 2018.
In its coverage of the leadership shakeup at FDA and the appointment of a new commissioner, NutraIngredients turned to Ivan Wasserman for comment.
see all news >